Altimmune (NASDAQ:ALT) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Altimmune beat estimated earnings by 16.67%, reporting an EPS of $-0.4 versus an estimate of $-0.48.
Revenue was down $11 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 4.29% drop in the share price the next day.
Here's a look at Altimmune's past performance:
To track all earnings releases for Altimmune visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
